EPI Update, February 17, 2012 by unknown
EPI Update for Friday, February 17, 2012 
Center for Acute Disease Epidemiology (CADE) 
Iowa Department of Public Health (IDPH) 
  
Items for this week’s EPI Update include: 
 Skin infections associated with tattoos 
 Foodborne illness linked to clover sprouts 
 Update on Adolescent Immunization Schedule 
 Meeting announcements and training opportunities 
  
Skin infections associated with tattoos 
IDPH is investigating a possible cluster of atypical mycobacterium skin infections among 
persons receiving tattoos at a central Iowa tattoo parlor between May 2011 and 
February 2012. 
  
Health care providers with a case(s) of atypical mycobacterial (e.g. M. chelonae) skin 
infection diagnosed between May 2011 and February 2012 (especially after tattooing) 
are encouraged to report to IDPH via phone at 515-281-7462 or e-mail by hitting reply 
to this update. 
  
Foodborne illness linked to clover sprouts 
IDPH, along with CDC and other state health departments, is conducting an 
investigation of a multi-state outbreak of Shiga toxin-producing E. coli O26 (STEC O26) 
infections linked to raw clover sprouts. Health care providers with patients who may 
have become ill after eating sprouts are asked to obtain a stool sample to be sent to the 
State Hygienic Laboratory for testing.  
  
Recommendations: 
 Iowans, especially children, older adults, pregnant women, and persons with 
weakened immune systems should avoid eating raw sprouts of any kind 
(including alfalfa, clover, radish, and mung bean sprouts). 
 If sprouts are going to be eaten, cook them thoroughly to kill pathogenic bacteria. 
  
For more sprout information, visit www.foodsafety.gov/keep/types/fruits/sprouts.html. For 
information about the multi-state outbreak of STEC O26, visit 
www.cdc.gov/ecoli/2012/O26-02-12/index.html. 
  
Update on Adolescent Immunization Schedule 
Some of the changes to the previous schedules include: 
 Quadrivalent meningococcal conjugate vaccine (MCV4) has been extended to 
reflect licensure of MCV4-D (Menactra) use in children as young as age 9 
months.  
 Guidance for administration of hepatitis B (Hep B) vaccine in infants with birth 
weights <2,000 grams and ≥2,000 grams. Clarification is provided for doses after 
administration of the birth dose of Hep B vaccine. 
 Haemophilus influenzae type b (Hib) conjugate vaccine and the use of Hiberix for 
the booster (final) dose are clarified. Guidance for the use of Hib vaccine in 
persons aged 5 years and older in the catch-up schedule has been updated.  
 Influenza vaccine information updated to clarify dosing for children aged 6 
months through 8 years for the 2011–12 and 2012–13 seasons. 
 Information on the recommended age (16 years) for the booster dose of MCV4. 
 Tdap vaccine recommendations for children aged 7 through 10 years are 
updated.  
 Human papillomavirus (HPV) vaccine includes routine recommendations for 
males. 
  
To view the full MMWR article and schedule, visit  
www.cdc.gov/mmwr/preview/mmwrhtml/mm6105a5.htm?s_cid=mm6105a5_e 
  
Meeting announcements and training opportunities 
None 
  
Have a healthy and happy week!  
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